Thomas Cho
About Thomas Cho
Thomas Cho is a Scientific Review Officer at The National Institutes of Health, specializing in structural modeling and molecular dynamics related to infectious and inflammatory diseases. He has held research positions at notable institutions including Texas A&M University, Yale University, and Saint Louis University, and has a strong background in protein engineering and therapeutic candidate development.
Work at National Institutes of Health
Thomas Cho has been serving as a Scientific Review Officer at the National Institutes of Health (NIH) since 2018. In this role, he is responsible for evaluating scientific research proposals and ensuring they meet the necessary standards for funding and advancement. His work contributes to the NIH's mission of fostering innovative research that enhances health and well-being.
Previous Positions in Academia
Before joining the NIH, Thomas Cho held several academic positions. He worked as a Research Scientist at Texas A&M University from 2017 to 2018. Prior to that, he served as an Associate Research Scientist at Yale University School of Medicine from 2009 to 2012 and as an Assistant Professor at Saint Louis University School of Medicine from 2012 to 2017. He also completed a postdoctoral fellowship at Yale University School of Medicine from 2005 to 2009.
Education and Expertise
Thomas Cho earned his PhD in Medical Sciences from Texas A&M University, where he studied from 1999 to 2005. He also holds an M.S. in Molecular Biology from Korea University, obtained between 1996 and 1999, and a B.S. in Biochemistry from Hanyang University, completed from 1987 to 1995. His educational background supports his expertise in structural modeling, molecular dynamics, and protein engineering.
Research Focus and Methodologies
Thomas Cho's research focuses on structural modeling and molecular dynamics, particularly in the context of infectious and inflammatory diseases. He engages in protein engineering and develops therapeutic candidates using advanced techniques such as X-ray crystallography and nuclear magnetic resonance (NMR). His work aims to enhance the understanding of disease mechanisms and contribute to the development of new treatments.